Effects of Doxycycline, Esomeprazole, Lidocaine, Rapamycin, Glibenclamide, Ketamine, Tris Buffer and Their Combinations on Anaplastic Thyroid Cancer Cells: A dataset on the anticancer effects of drugs and their combinations

The raw data were submitted as supplementary file with the article. The file has five dataset of absorbance reading of the wells in 96 plate and cell viablilty rate caculated for each drug or drug combination. These data were analysed and the analysed data were presented in tables and figures. In figure 1, The inhibition rate of Esomeprazole, Lidocaine, Rapamycin, Glibenclamide and Ketamine was compared to that of their combinations. In figure 2, The inhibition rate of Esomeprazole, Glibenclamide and Doxycycline was compared to that of their combinations. In figure 3, The inhibition rate of Doxycycline, Rapamycin, Ketamine and Tris Buffer was compared to that of their combinations. The inhibition rate of each drug and their combination was presented in table 1. For identifying synergistic drug combinations, Q value was calculated for each drug combination using Jin's formula and was demonsterated in table 2.

原始数据以补充文件的形式随文章提交。该文件包含五个数据集，分别记录了96孔板中各孔的吸光度读数以及针对每种药物或药物组合计算出的细胞活力率。对这些数据进行了分析，并将分析结果以表格和图表的形式呈现。在图1中，对比了艾司奥美拉唑、利多卡因、雷帕霉素、格列本脲和ketamine的抑制率与其组合的抑制率。在图2中，对比了艾司奥美拉唑、格列本脲和强力霉素的抑制率与其组合的抑制率。在图3中，对比了强力霉素、雷帕霉素、ketamine和三羟甲基氨基甲烷缓冲液的抑制率与其组合的抑制率。每种药物及其组合的抑制率均在表1中呈现。为识别协同药物组合，针对每种药物组合利用金公式计算出Q值，并在表2中进行展示。